Hartalega's founder directors acquisition of shares is a positive sign that the share price is currently undervalued.

To date, Hartalega is the largest nitrile glove producer in the world with a 96% Nitrile 4% Others mix.

Compared to the 2nd largest nitrile glove producer, Top Glove of 47% nitrile and 53% latex and others.

Investors are beginning to uncover that the world's medical industry are short of nitrile gloves, not latex gloves, thus the sell down in Top Glove and Supermax shares to reposition to Hartalega shares.

Hartalega has also the largest customer base in US and medical industry compared to other glove producers.

The acute glove shortage in the world is most beneficial to Hartalega compared to other glove producers as other glove producers customer mix are saturated.

Further catalyst is Hartalega's patented AMG Antimicrobial gloves approval by FDA which will create further premium valuation.